Evidence map›Paper›PMID 40529169›Full record

ArticleFrontiers in bioengineering and biotechnology2025

Deteriorated biomechanical properties of human hypertrophied septum in response to cardiomyocyte enlargement, overexpressed collagen, and disarrayed microstructures.

Katherine M Copeland, Houjia Chen, Uday Chintapula, Milad Almasian, Duc Khang Chung, Alan M Taylor, Yichen Ding, Gaurav Sharma, Michael E Jessen, Yi Hong and 4 more

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Katherine M CopelandDepartment of Bioengineering, University of Texas at Arlington, Arlington, TX, United States.
Houjia ChenDepartment of Bioengineering, University of Texas at Arlington, Arlington, TX, United States.
Uday ChintapulaDepartment of Bioengineering, University of Texas at Arlington, Arlington, TX, United States.
Milad AlmasianDepartment of Bioengineering, University of Texas at Dallas, Richardson, TX, United States.
Duc Khang ChungDepartment of Bioengineering, University of Texas at Arlington, Arlington, TX, United States.
Alan M TaylorDepartment of Bioengineering, University of Texas at Arlington, Arlington, TX, United States.
Yichen DingDepartment of Bioengineering, University of Texas at Dallas, Richardson, TX, United States.
Gaurav SharmaDepartment of Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Michael E JessenDepartment of Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Yi HongDepartment of Bioengineering, University of Texas at Arlington, Arlington, TX, United States.
Kytai T NguyenDepartment of Bioengineering, University of Texas at Arlington, Arlington, TX, United States.
Matthias PeltzDepartment of Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Pietro BajonaDepartment of Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Jun LiaoDepartment of Bioengineering, University of Texas at Arlington, Arlington, TX, United States.

Funding

CONTROL OF CARDIAC FIBROSIS TO PREVENT CARDIAC FUNCTION DETERIORATIONR01EB022018 · NIBIB · WASHINGTON UNIVERSITY · PI GUAN, JIANJUN · 2016 to 2018
$1.1M
A Controlled Septal Ablation for Inoperable Hypertrophic CardiomyopathyR15HL159599 · NHLBI · UNIVERSITY OF TEXAS ARLINGTON · PI LIAO, JUN · 2022 to 2022
$433k
NHLBI NIH HHS R15 HL159599NIBIB NIH HHS R01 EB022018
6 · The paper itself

Abstract

Hypertrophic cardiomyopathy (HCM) is often caused by genetic mutations, resulting in abnormal thickening of ventricular muscle, particularly the septum, and causing left ventricular outflow tract (LVOT) obstruction and inferior cardiac performance. The cell and microstructural abnormalities are believed to be the cause of the altered tissue mechanical properties and inferior performance. However, there is a lack of detailed biomechanical assessments of human hypertrophied septum and a lack of understanding of the structural-mechanical relationship between altered biomechanical properties and cellular hypertrophy, fibrotic overexpression, and microstructural disruptions. In this study, we performed thorough biomechanical and microstructural characterizations on the human hypertrophied septum and compared this with healthy septum. We found that the hypertrophied human septum was stiffer at the initial phase of tissue loading, but less nonlinear, less stiff in the linear region, and much weaker in mechanical strength when compared to the healthy human septum. The fibrosis-induced initial stiffening in the hypertrophied septum paradoxically coexists with compromised mechanical strength and integrity under physiological demands, correlating with the clinical observations of diastolic dysfunction and susceptibility to myocardial damage in HCM patients despite ventricular wall thickening. We also discovered that the human hypertrophied septum had significantly larger stress relaxation and slightly larger creep when compared to healthy septum. Moreover, the abnormal, disorganized cell-collagen microstructures in the hypertrophied septum make short-term stress release more difficult and require longer relaxation times to reach equilibrium. Biaxial testing performed at the initial phase of tissue loading showed that both the healthy septum and hypertrophied septum had nonlinear anisotropic stress-strain behavior and confirmed that, in the longitudinal direction, the hypertrophied septum was stiffer than the healthy septum. Our microstructural quantifications via histology and light-sheet microscopy revealed that (i) the heterogeneous cardiomyocyte enlargement and disarray, combined with disorganized collagen overexpression, create a mechanically inefficient tissue architecture in the hypertrophied septum, and (ii) the observed cell-collagen microstructural disruptions provide mechanistic explanations for the deteriorated biomechanical properties. Our viscoelastic mechanical data and microstructural characterizations build a strong foundation to understand the altered tissue behavior of the hypertrophied septum, the degree of deviation from the normal septum, and the underlying structural mechanisms.

Indexed as

and applications in multi-scale mechanobiologybiomechanical deteriorationcollagen overexpressionconceptsemerging toolshuman hypertrophied septumhypertrophic cardiomyopathymicrostructural abnormalities

Identifiers

PMID40529169
PMCPMC12171370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.